UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement |
| ☒ | Definitive Additional Materials |
| ☐ | Soliciting Material under §240.14a-12 |
Emergent BioSolutions Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| ☒ | No fee required. |
| ☐ | Fee paid previously with preliminary materials. |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
On April 16, 2026, Emergent BioSolutions Inc. sent the following message to its employees.
Annual Meeting of Stockholders Coming Up, A Reminder to Vote
The 2026 annual meeting of Emergent stockholders will be April 29, 9 a.m. Eastern Time.
The big picture: If you are an eligible shareholder (vested shares as of March 6, 2026), be sure to vote.
| • | Even if you can’t attend the virtual meeting, you can still vote by proxy. |
What’s next: Look for an E*TRADE email with details on how to vote.
| • | Search your inbox for the email from id@proxyvote.com. |
If you’re having trouble with account access, contact customer service.